Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 153Neoplasms 112Carcinoma, Non-Small-Cell Lung 85Colorectal Neoplasms 81Prostatic Neoplasms 80Lung Neoplasms 73Leukemia, Myeloid, Acute 50Carcinoma, Hepatocellular 48Pancreatic Neoplasms 46Neoplasm Metastasis 40Multiple Myeloma 37Recurrence 35Triple Negative Breast Neoplasms 29Squamous Cell Carcinoma of Head and Neck 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Melanoma 27Glioblastoma 27Ovarian Neoplasms 26Brain Neoplasms 26Uterine Cervical Neoplasms 25Head and Neck Neoplasms 25Stomach Neoplasms 24Rectal Neoplasms 24Small Cell Lung Carcinoma 22Carcinoma, Renal Cell 20Lymphoma, B-Cell 19Glioma 19Lymphoma, Follicular 18Lymphoma 18Endometrial Neoplasms 18

Interventions

(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Ventricular Dysfunction, Left × 90 days × Clear all
NCT07572175 2026-05-07

SPARTACUS

Icahn School of Medicine at Mount Sinai

Phase 2 Not yet recruiting
60 enrolled
Lymphoid

Lymphoma, Ventricular Dysfunction, Left, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡